[1]
Kalinauskaitė-Žukauskė, V. 2020. BIOLOGICAL THERAPY WITH BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA: ADVANTAGES AND UNANSWERED QUESTIONS. Pulmonology and allergology. 4, 2 (Sep. 2020), 168-179. DOI:https://doi.org/10.37499/PIA.120.